Skip to content
Screener

Arvinas ARVN Accrued Expenses

Accrued Expenses at other companies

Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$13.45M+7.4%
LON
LeonaBio, Inc.LONA
$4.42M+5.4%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$236K+102%
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$7.16M+80.5%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$16.17M+91.3%
Immunome logo
ImmunomeIMNM
$29.72M+63.1%

Other financials

Income statement

See full
Revenue$15.6M-91.7%
Operating income-$63.8M-189%
Net income-$57.6M-169%
EPS (diluted)-$0.90-179%

Balance sheet

See full
Cash & equivalents$87.3M+7.8%
Total debt$8.6M-19.6%
Total equity$386.8M-41.4%
Total assets$647.5M-35.3%

Cash flow

See full
Operating cash flow-$69.2M+22.2%
CapEx$1.3M+225%
Free cash flow-$70.5M+21.1%

Valuation

See full
Market cap$587.82M+21.6%
Enterprise value$509.12M+34.5%
P/S6.6×+5.3×

Profitability

See full
Operating margin-283.8%-310pp
Net margin-247.5%-260pp
FCF margin-287.4%

Returns & leverage

See full
Return on equity-42.3%-53.5pp
Debt / equity0.0×
Current ratio5.4×+0.9×

Where this comes from

Reported directly by Arvinas in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The source filing: Arvinas’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 5:18 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-033669
(dollars in millions)March 31,2026December 31,2025
Accounts payable$31.4$24.4
Accrued liabilities
Research and development expenses17.418.2
Employee expenses4.517.5
Income taxes5.04.8
General and administrative and commercial expenses2.43.7
Professional fees1.60.9
Total accounts payable and accrued liabilities$62.3$69.5

Item 1. Financial Statements (Unaudited)

FAQ

What is Arvinas's accrued expenses?
Arvinas (ARVN) reported accrued expenses of $4.5M in Q1 2026.
How has Arvinas's accrued expenses changed year-over-year?
Arvinas's accrued expenses decreased by 40.8% year-over-year, from $7.6M to $4.5M.
What is the long-term trend for Arvinas's accrued expenses?
Over 5 years (2020 to 2025), Arvinas's accrued expenses has grown at a -1.5% compound annual growth rate (CAGR), from $18.9M to $17.5M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.

Ask your AI about Arvinas's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude